In the specialized field of biochemical research, navigating the nomenclature of various compounds can be complex. When researchers ask, "what is 3 mog peptide," they are often referring to the specific study of MOG peptides—specifically the MOG (35-55) fragment. It is important to clarify that this is a research-grade tool used strictly in controlled laboratory settings, such as immunology and neuroscience studies, and is not for personal or human use.
Defining the MOG Peptide Entity
Myelin oligodendrocyte glycoprotein (MOG) is a membrane-bound glycoprotein that plays a sig Dec 17, 2025 — Serum myelin oligodendrocyte glycoprotein (MOG) antibodies are a hallmark of the newly defined neuroinflammatory disease entity MOG nificant role in the structure of the central nervous system. It is a transmembrane protein expressed on the surface of oligodendrocyte cells and is found on the outermost surface of myelin sheaths.
The specific fragment often discussed, MOG Protein (35-55), represents a high quality epitope peptide. In academic literature, you will often find three distinct variations of these sequences being evaluated for their specific biological properties. Scientists utilize these sequences because MOG is a glycoprotein uniquely expressed in oligodendrocyte membranes and myelin sheath, making it an essential subject for studying immune system interactions within the nervous system.
The Role of MOG (35-55) in Research Models
The MOG (35-55) peptide is widely recognized for its use as an antigen/immunogen in experimental models. Because MOG (35-55) is highly encephalitogenic, it is frequently employed in laboratory settings to study immune-mediat MOG Antibody Disease Information ed responses.
When researchers examine MOG 35-55 human sequences (MEVGWYRPPFSRVVHLYRNGK) versus murine variants, they are looking at how these sequences trigger specific T and B cell responses. In these controlled environments, the administration of the peptide is designed to mimic aspects of neuroinflammatory processes. For instance, studies have shown that MOG (35-55) produces a relapsing-remitting neurological disease in specific animal models, which allows investigators to observe the mechanisms of myelin degradation or the development of MOG Antibody Disease (MOGAD) markers in a labo Myelin Oligodendrocyte Antibody Disease Fact Sheet ratory context.
Technical Specifications and Variations
When sourcing these materials for research, precision i Human (MOG 1-125) and (MOG-35-55) Myelin s paramount. Whether dealing with the murine or human variant, the purity of the Myelin oligodendrocyte glycoprotein (MOG) peptide is critical for consistent results.
* Structure: It is a type of protein involved in cell adhesion.
* Molecular Context: As a membrane-bound glycoprotein, it provides a scaffold for studying how the immune system recognizes self-antigens.
* Experimental Utility: Researchers often use Myelin Oligodendrocyte Glycoprotein P MOG Disease and Treatments | Mass General Brigham eptide (35-55) to investigate the efficacy of potential therapeutic candidates, such as the Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate, which aims to modulate immune responses.
Observations on Research Applications
My personal interest in this field stems from observing how the 3 most common MOG peptide variants are used to map the landscape of protein-ligand interactions. It is fascinating to see how Myelin oligodendrocyte glycoprotein MOG (35-55) serves as a foundational tool for understanding how the body maintains the integrity of the CNS.
While the scientific community continues to explore the nuances of these peptides—including their role in omyelitis-related research and broader neuro-immunological studies—it remains clear that these tools are strictly for the advancement of our understanding of protein function. The complexity of how these proteins interact with the immune system is a testament to the precision required in modern biochem Myelin Oligodendrocyte Antibody Disease Fact Sheet ical research, necessitating high-purity, well-characterized sequences for every experiment.
By focusing on these specific protein fragments, rese Myelin oligodendrocyte glycoprotein MOG (35-55) is widely used in models of neuronal injury induced by MPTP as well as autoimmune models of multiple sclerosis. archers can continue to decipher the intricate relationship between the CNS and immune surveillance, moving closer to the mechanisms that define these complex biological interact Patient-Derived Monoclonal Myelin Oligodendrocyte ions.